Reference: GILA/LC/LC03/2608
Entity: Large Indian equity-listed company; client name confidential
Seat: Independent Director, Non-Executive
Primary board geography: Mumbai with manufacturing and dealer-market visits across western and southern India
Expected governance cadence: Six boards, six Audit meetings, quarterly Risk reviews and two market/plant immersions
Status: Confidential retained search; identity released after conflict pre-clearance and NDA.
Anonymised corporation profile
A large listed decorative and industrial coatings company with nationwide dealer distribution, owned manufacturing, contractor/influencer programmes and a growing waterproofing and construction-chemicals portfolio.
Revenue exceeds ₹20,000 crore. The company is commissioning major capacity while competitive intensity, crude-linked raw materials, dealer credit, tinting assets, premiumisation and adjacent-category investment reshape returns.
Calibrated market hint: The combination of decorative leadership, industrial coatings and aggressive adjacent-category expansion points to a handful of large listed paint groups. Any candidate inference must remain confidential and be disclosed to GILA solely for conflict screening.
Why this board seat exists
The incoming independent director is expected to chair Audit and bring commercial judgement to channel economics. The board must see the difference between primary sales, dealer inventory, consumer offtake and sustainable market share.
This is a large-corporation stewardship appointment, not a prestige seat. The director will be expected to form a view independently of promoter, management, government, lender, customer and institutional-investor pressure—and to ensure dissent, conditions and unresolved evidence are accurately minuted.
Board position, committee authority and boundaries
Independent Director; Audit Committee Chair; member of Risk and Investment review; direct private sessions with statutory audit, internal audit, CFO and channel-control leaders.
The appointee sets questions, risk appetite, evidence standards and accountability. Management owns execution. The director must not become a shadow executive, transaction sponsor, government liaison, vendor selector or paid adviser to the business.
Strategic charter — first 18–24 months
- Establish channel-level reporting for primary sales, secondary offtake, dealer inventory, tinting-machine placement, credit, rebates, returns and collections
- Test revenue cut-off, scheme accruals, loyalty, contractor and influencer payments for side arrangements
- Review crude-linked raw-material, currency and inventory exposure with procurement and pricing decisions
- Govern new-plant capital, commissioning, utilisation, product qualification and post-investment audit
- Examine warranty, shade, waterproofing, product-performance and consumer-claim provisioning
- Review dealer concentration, related distributors, depots and logistics controls
- Challenge acquisition or incubation economics for construction chemicals and services
- Strengthen whistleblower, distributor-conduct and competitive-information protocols during an intense market-share cycle
Decisions expected to reach the board
- Whether primary-sales growth reflects genuine offtake
- Whether new capacity should ramp despite weak pricing
- Whether an adjacent category deserves further capital after customer-acquisition and warranty costs
The search will test how the candidate makes these decisions with incomplete information, competing stakeholder interests and material downside—not whether the candidate can recite a governance framework.
Candidate evidence sought
Essential
- Consumer/manufacturing CFO, audit partner, coatings/chemicals executive or distribution leader with Audit Chair capability
- Deep inventory, channel and incentive-accounting judgement
- Experience governing major capacity and category expansion
- Independence from dealer and supplier ecosystems
Strong differentiators
- Listed consumer-company Audit Committee chairmanship
- Channel-loading or rebate-control remediation
- Paints, chemicals, building products or route-to-market depth
- Large greenfield plant or acquisition post-audit experience
GILA will test intellectual independence, preparedness, dissent behaviour, information discipline, crisis judgement and the ability to remain non-executive while still being consequential.
Statutory, listing and independence gates
Candidates must satisfy the then-current Companies Act, SEBI LODR and entity/sector requirements, including Section 149(6) independence; IICA Databank and proficiency/exemption status; valid DIN/KYC; Sections 164–165; Schedule IV; applicable listed-board and committee ceilings; Regulation 16 independence; Regulation 17A directorship limits; Regulation 26 committee limits; and any sector fit-and-proper or regulatory approval. Appointment, reappointment or removal will follow applicable shareholder-approval requirements.
Independent Directors cannot receive stock options. Securities ownership and trading, relatives’ interests, former employment, pecuniary relationships, audit/advisory look-backs, promoter-group exposure and interlocking directorships will be verified against current law and the client’s complete group structure.
Mandate-specific conflict screens
Relationships with raw-material suppliers, dealers, contractors, architects, influencers, competitors, auditors, advisers or land/EPC counterparties; commercial property leased to the group; brand endorsement interests.
Candidates carrying near-limit board portfolios, recurring consulting practices or commercial introduction expectations will be assessed for real availability and independence even where technical ceilings are not breached.
First-year board outcomes
- Channel inventory and schemes reconcile to cash and offtake
- Plant capital follows commissioning and return gates
- Product/warranty issues reach provisions promptly
- Audit can explain margin and market-share economics without management-adjusted narratives
Time, indicative remuneration and protection
- Expected commitment: 28–35 days annually, with close, results and site peaks.
- Sitting fees: At the company’s approved rate, up to the statutory ceiling per eligible Board or committee meeting; actual meeting count and eligibility govern payment.
- Expenses: Board-approved travel and participation expenses reimbursed at actuals and excluded from the indicative range.
- No equity: No stock options for an Independent Director. No transaction success fee, vendor commission, customer referral fee or separate promoter/fund compensation.
- Approval caveat: NRC and Board recommendation, shareholder approval and any special resolution required under SEBI LODR—including concentration of remuneration among non-executive directors—must be obtained.
- Protection: Appointment letter, statutory access and information rights, D&O appropriate to the enterprise and top-listed-entity requirements, advancement of defence costs, investigation/securities cover, run-off after cessation, minuting of dissent and access to independent professional advice.
Search and appointment process
Conflict pre-clearance → GILA/SYMPHONY™ listed-board assessment → sector-specific decision case → regulator/reputation and statutory checks → reference triangulation with board peers and control functions → NRC interaction → independent-director and full-board interviews → document-led candidate diligence under NDA → special-resolution/shareholder process and regulatory approval where applicable.